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Summary
 
A homozygous 24-bp deletion (
 
D
 
24) was found in the CC chemokine receptor 5 (CCR5) of 11
out of 15 red-capped mangabeys (RCMs), 
 
Cercocebus torquatus torquatus
 
, both in Africa and in an
American zoo. The CCR5 
 
D
 
24 defect encompassed eight amino acids in frame in the fourth
transmembrane region. Unexpectedly, RCM-009, one of 11 homozygotes (
 
D
 
24CCR5/
 
D
 
24CCR5), was found to be naturally infected with a divergent simian immunodeficiency
virus (SIV) strain, which was not R5-tropic, but used CCR2b (R2b) as its major coreceptor.
SIVrcmGab1 was the only R2b-tropic SIV among other divergent SIVs tested. Cells trans-
fected with the 
 
D
 
24 CCR5 did not support entry of R5-tropic SIVmac, SIVcpz, SIVmne,
HIV-2, or HIV-1, and were also inactive in signal transduction mediated by 
 
b
 
-chemokines. At
86.6%, the 
 
D
 
24 allelic frequency was significantly higher than that of the 32-bp deletion found
in humans. The 
 
D
 
24 frequency was 4.1% in 34 sooty mangabeys (SMs), a geographically iso-
lated subspecies that was naturally infected with R5-tropic SIV. Finding identical deletions in
two mangabey subspecies separated for 10,000 years or more dates the 
 
D
 
24 CCR5 deletion as
ancient. However, the source of the selective pressure for the high rate of CCR5 deletion in
RCMs remains to be determined. The high allelic frequency of the 
 
D
 
24 CCR5 in RCMs, in
comparison to that of SMs, suggests that R2b-tropism may have been acquired by SIVrcm, as
an adaptation to CCR5 genetic defects appeared in its host.
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A
 
fter human immunodeficiency viruses types 1 (HIV-1)
and 2 (HIV-2) were identified as causes of AIDS (1,
2), multiple non-human primate species in Africa were
found to harbor their own divergent lentiviruses, the sim-
ian immunodeficiency virus (SIV)
 
1
 
 group (3–9). Six simian
species in Africa are known to be naturally infected, the
sooty mangabey (SM), 
 
Cercocebus torquatus atys
 
, in West Af-
rica (6, 7); the four subspecies of African green monkeys
(AGM), 
 
Cercopithecus aethiops
 
, in East, Central, and West
Africa (3, 10); the Sykes monkey, 
 
Cercopithecus mitis
 
, in
Kenya (8); the mandrill, 
 
Mandrillus sphinx
 
, in Gabon (4);
and the chimpanzee (CPZ), 
 
Pan troglodytes
 
, in Gabon (5).
We recently identified a new sixth lineage from a red-
capped mangabey (RCM), 
 
Cercocebus torquatus torquatus
 
,
that was naturally infected in Gabon (9). Phylogenetic anal-
ysis of 
 
pol
 
 gene fragments showed an unexpectedly close
relationship with the HIV-1/SIVcpz group of viruses,
whereas analysis of 
 
gag
 
 gene sequences indicated a new lin-
eage, independent from previously characterized SIVs (9).
Additional sequence analysis of SIVrcm 
 
gag
 
 and 
 
env
 
 genes
have also shown regions with relatively closer relationships
with SIVagm and SIVsm (Gao, F., P.A. Marx, and B.
Hahn, unpublished data). Therefore, SIVrcm appears to
 
1
 
Abbreviations used in this paper:
 
 AGM/agm, African green monkey; CPZ/
cpz, chimpanzee; GFP, green fluorescent protein; MIP, macrophage in-
flammatory protein; RCM/rcm, red-capped mangabey; SIV, simian im-
munodeficiency virus; SM/sm, sooty mangabey.
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have been generated by ancient recombinations involving
ancestors of the sixth independent SIVrcm lineage and an-
cestors of the current HIV-1/SIVcpz and SIVagm groups.
Because the SIV family is genetically divergent and natu-
rally infects simians geographically isolated in Africa from
thousands of years (3–10), SIV must have arisen in Africa
long before the AIDS epidemic in humans and long before
the earliest known HIV-1 infection in Africa (11). The an-
cient age of SIV offers the opportunity to experimentally
study evolution of long-term, nonpathogenic virus–host
relationships in comparison to the disease states found in
the more recent human and macaque hosts (11, 12). Be-
cause of the unique phylogenetic features of SIVrcm, fur-
ther characterization of its biological functions were done
to understand its virus–host relationships.
The entry of HIV and SIV into host cells requires cell
surface CD4 as a primary receptor to interact with the viral
envelope (13). However, human CD4 molecules them-
selves, when expressed on non-human cell lines, do not
render the cells susceptible to HIV-1 infection (14), sug-
gesting that an additional cell surface receptor was required.
Such coreceptors were identified on human CD4-bearing
cells as belonging to the chemokine receptor family, all of
which consists of surface seven-transmembrane G protein–
coupled receptors (15–20).
Syncytia-inducing (SI) HIV strains that infect T cell lines
are frequently found in late-stage HIV disease. These vi-
ruses generally use the chemokine receptor CXCR4 (15),
the first chemokine coreceptor identified. In contrast, mac-
rophage-tropic viruses that are non-syncytium-inducing
(NSI), and may be found throughout the disease course,
use CCR5 (16–20). CCR5 is the receptor for CC che-
mokines RANTES (regulated on activation, normal T cell
expressed and secreted), macrophage inflammatory protein
(MIP)-1
 
a 
 
and MIP-1
 
b
 
, all of which block cell entry of
NSI strains of HIV-1 (21–23). CXCR4 is a receptor for
the CXC chemokine SDF-1, which blocks entry of some
SI HIV-1 strains (22, 23). Several HIV-1 isolates use multi-
ple coreceptors CCR2b, CCR3, and CXCR4, in addition
to CCR5 (19, 24). Unlike HIV-1, SIVs from monkeys are
known to use the CC chemokine CCR5, but not
CXCR4, for entry, regardless of their T cell or macro-
phage tropism (25–27). Additional coreceptors, GPR15,
STRL33 and GPR1, mediate entry of some primary SIV
isolates, probably accounting for SIV entry into CCR5-
deleted PBMCs and T cell lines (25, 28–31).
HIV-1 CCR5-tropism is critical in HIV transmission
and pathogenesis because homozygous 
 
D
 
32 deletions were
shown to confer resistance to infection against R5-tropic
HIV-1 strains (32). Further molecular epidemiological stud-
ies showed that a homozygous defect in CCR5 was protec-
tive against HIV-1 transmission, whereas a heterozygous
defect slightly delayed progression to AIDS (33–35). In
contrast, similar defects and their role in protection against
infection have not been documented in any non-human
primate species.
In this study, we found that coreceptor usage by
SIVrcmGab1 (9) was unique among divergent SIVs in that
 
it used CCR2b but not CCR5 as a major coreceptor. To
test for a genetic basis for this finding, we sequenced the
CCR5 gene in a naturally infected RCM host. A homozy-
gous 24-bp in-frame deletion (
 
D
 
24) in the fourth trans-
membrane region of CCR5 gene was found in the infected
mangabey. The identical homozygous deletion was found
in 11 out of 15 unrelated RCMs from widespread locations
in Africa and the USA. The remaining four RCMs were
heterozygotes. These results yielded a very high allelic fre-
quency of 86.6%. The homozygous 
 
D
 
24 CCR5 genotype
did not support R5-tropic lentivirus infections and failed in
signal transduction assays mediated by 
 
b
 
-chemokines. The
results show that a natural simian lentivirus infection can
occur in the presence of CCR5 gene deletions without ev-
idence of disease and that the mangabey deletion is ancient
in comparison to the reported age of the CCR5 deletion in
humans.
 
Materials and Methods
 
Virus Preparation.
 
The preparation of virus stocks HIV-1
JR-FL, HIV-1 Z00979, HIV-2 A198411, HIV-2 A227011,
SIVmac239, SIVcpzGab1, SIVmac1A11, and SIVagmTYO1 has
been described previously (25, 31). SIVrcmGab1 was obtained
from RCM-009, a naturally infected household pet in Gabon (9).
HIV-2 A198411 and HIV-2 A227011 strains were provided by
Dr. Beatrice Hahn (36) and were primary isolates from West Af-
rica that were propagated and titered in human PBMCs in our
laboratory as previously described (31). Luciferase reporter viruses
were prepared by cotransfecting 293T cells with pNL-Luc-Env
 
2
 
or pSIV-Luc-R
 
2
 
E
 
2
 
 and vectors expressing different SIV or HIV-1
Envs, as previously described (16, 25).
 
Animals.
 
All animal care and use was approved by the institu-
tional animal care committees.
 
Tissue Culture.
 
RCM
 
 
 
PBMCs were prepared by Ficoll gradi-
ent separation, as previously described (7). Human osteosarcoma
HOS.CD4 and glioma U87.CD4 cells, which stably express hu-
man and non-human primate chemokine receptors, have been
described previously (25). GHOST.CD4 cl.34 cells are human
osteosarcoma cells expressing human CD4 and containing the
green fluorescence protein (GFP) gene controlled by the HIV-2
LTR promoter as the indicator of lentivirus infection.
GHOST.CD4.Hu-BOB and GHOST.CD4.Hu-Bonzo cells,
which express human coreceptors BOB (GPR-15) and Bonzo
(STRL33), were provided by V.N. KewalRamani of New York
University Medical Center.
 
Cell Separation from Feces.
 
Fecal specimens from free-living
mangabeys in Gabon were collected fresh by spreading plastic
sheets under a tree being used for sleeping by a wild mangabey
troop. The mangabeys were observed through binoculars in late
afternoon, to verify the species of the individual depositing the
specimen. The specimen was collected immediately after it
dropped to the plastic. In the field, 35 ml PBS was added to 10 g
of fresh feces and suspended by shaking and vortexing. The fecal
suspension was layered onto 15 ml of lymphocyte separation
medium (Organon-Teknika, Durham, NC). Using a portable
centrifuge, the mixture was spun at 3,000 rpm for 20 min. Cells
were harvested at interface, in a volume of 
 
z
 
15 ml. If the cell
layer was diffuse after a single centrifugation, medium above and
below the interface was collected. The ficoll separation step was
repeated up to five times, using 3.0 ml of lymphocyte separation 
2059
 
Chen et al.
medium, until the cell layer was clearly defined. Cells were sus-
pended in 10 ml PBS, washed twice, and stored in a portable liq-
uid nitrogen tank.
 
Analysis of Genomic DNA and Cellular RNA for CCR5 Dele-
tion.
 
The full length RCM-CCR5 was amplified as previously
reported (25) for rhesus CCR5, using primers that flank the en-
tire CCR5 coding region. PCR primers that hybridized 5
 
9
 
 and 3
 
9
 
to a 
 
ccr5
 
 region flanking the 
 
D
 
24 deletion were as follows: 5
 
9
 
primer (nucleotides 318–343 in the CCR5 coding region):
5
 
9
 
-GCT CTA TTT TAT AGG CTT CTT CTC TG-3
 
9
 
, and
3
 
9
 
 primer (510–530): 5
 
9
 
-GTG TAA TGA AGA CCT TCT
CTC TGA GAT CTG-3
 
9
 
. Using this primer pair, 189 or 213 bp
 
ccr5
 
-specific fragments with and without the 24-bp deletion were
amplified from genomic DNA (0.5 
 
m
 
g). The PCR reaction was
according to the manufacturer’s specifications (Boehringer Mann-
heim, Indianapolis, IN) in 100 
 
m
 
l containing 10 mM Tris-HCl
(pH 8.5), 50 mM KCl, 1.5 mM MgCl
 
2
 
, 0.1% Triton X-100, 200
 
m
 
M each of dATP, dGTP, dCTP, and dTTP, 20 pmol of each
primer, and 0.5 U of DNA Taq polymerase (Boehringer Mann-
heim). Amplification cycles were 95
 
8
 
C for 2 min followed by 35
cycles of 95
 
8
 
C for 15 s, 55
 
8
 
C for 20 s, and 72
 
8
 
C for 20 s plus the
last extension of 72
 
8
 
C for 10 min. RNA was extracted from cells
using Triazol (GIBCO BRL, Gaithersburg, MD) and treated
with 10 U RNase-free DNase (Promega Corp., Madison, WI).
cDNA was prepared from 5 
 
m
 
g RNA using an oligo-dT primer
Superscript reverse transcriptase (GIBCO BRL), and resuspended
in 80-
 
m
 
l 10 mM Tris, pH 8.0, 1 mM EDTA (TE). The cDNA
was amplified over 35 cycles using the primer pair specific for the
 
ccr5
 
 fragment flanking the 
 
D
 
24 deletion as described above.
 
Plasmid Construction and Expression of RCM-CCR5.
 
The pro-
cedure for constructing expression plasmids was the same as that
described for rhesus CCR5 and CXCR4 (25). In brief, virus
stocks for the retroviral vectors expressing CCR5 and CXCR4,
pBabe/CCR5, and pBabe/CXCR4, respectively, were prepared
by cotransfecting 293T cells with the murine leukemia virus
(MuLV)-gag/pol vectors pSV-psi-MLV-env
 
2
 
 and pcVSV-G. Vi-
rus was harvested 48 h after transfection and frozen at 
 
2
 
70
 
8
 
C.
293, HOS.CD4, and U87.CD4 cells were infected at the same
time with 2 ml of the pBabe virus and were selected 48 h later in
culture medium containing 1.0 
 
m
 
g/ml puromycin (Sigma Chem-
ical Co., St. Louis, MO). Puromycin-resistant cells were then
used for HIV-1 and SIV infection with replication-competent or
luciferase reporter viruses.
 
Virus Entry Assay.
 
To test for viral entry, 3 
 
3 
 
10
 
4
 
 cells were
seeded in 24-well plates in culture medium and infected with lu-
ciferase reporter virus (20 ng p24 or p27) in a total volume of 300
 
m
 
l containing 1 ng/ml polybrene. After incubation overnight, 1 ml
of medium was replaced in each well. After three days at 37
 
8
 
C,
100-
 
m
 
l lysates were prepared and luciferase activity in 20 
 
m
 
l was
measured using commercially available reagents (Promega Corp.).
For GFP assay, 2 
 
3 
 
10
 
4
 
 GHOST cells expressing coreceptors
were seeded into 24-well plates. After 24 h, 5 ng p27 of each SIV
was inoculated for 12 h with 20 
 
m
 
g/ml polybrene. Input virus
was removed by washing, and cells were maintained in DMEM
medium with 10% FCS. GFP expression was detected by FACS
 
Ò
 
analysis (Becton Dickinson, San Jose, CA) 48 h after infection.
 
Viral Infectivity Assays.
 
To determine coreceptor usage of dif-
ferent viruses, 2 
 
3 
 
10
 
4
 
 HOS.CD4 or U87.CD4 cells stably ex-
pressing human or rhesus coreceptors were seeded in 24-well
plates. The next day the adherent cells were washed with PBS
and infected with 5 ng p27 of SIV or 500 TCID
 
50
 
 of HIV-1. Af-
ter 12 h, virus was removed by replacing the medium three times.
The cells were maintained in medium with 2% FCS for up to 10 d.
Virus production was measured by harvesting aliquots of each
supernatant and measuring p27 (Coulter, Chicago, IL) or p24
(Abbot, Chicago, IL) by ELISA. After removing 0.5 ml of culture
supernatant per well for assay, the same amount of fresh medium
was added to the culture.
 
Calcium Ion Influx Assay Using Flow Cytometry.
 
The assay was
performed as previously described (37). In brief, 293 cells express-
ing RCM-CCR5 or RCM-
 
D
 
24-CCR5 were harvested from tis-
sue culture plates using a cell scraper. The cells were washed with
tissue culture medium before resuspending them at 106 cells/ml in
HBSS containing 0.5% (wt/vol) BSA, 4 mM probenicid (Sigma
Chemical Co.) and 4 mg/ml Fluo-3 AM, 10 mg/ml Fura-Red,
and 0.02% Plurionic F127 (all from Molecular Probes, Eugene,
OR). The cells were incubated at 378C for 30 min then centri-
fuged at 1,500 rpm for 5 min before being gently resuspended at
106 cells/ml HBSS containing 0.5% BSA. The cells were left at
room temperature for 20 min. All analyses were performed using
a FACSCaliburÒ flow cytometer with Cellquest software (Becton
Dickinson). Equal amounts of the cells were removed, further di-
luted to 106 per ml in HBSS containing 0.5% BSA and warmed
to 378C for 5 min. The sample temperature was maintained
throughout the assay by a water jacket at 378C. Data were col-
lected over a 3-min period 20 s after adding 200 nM b-chemo-
kines, MIP-1b, or RANTES. A ratio of Fluo-3/Fura-red fluores-
cence was calculated using FACS Assistant software (Ray Hicks,
Cambridge University, Cambridge, UK). Data are displayed as a
density plot of time verses fluorescence ratio and also as a line
graph of time versus mean fluorescence ratio, which was calcu-
lated using FACS Assistant Software.
Sequence Analysis. The complete sequence of RCM-CCR5
was obtained using an automated sequencer (ABI Prism 377
DNA Sequencer; PE Applied Biosystems, Foster City, CA). At
least two molecular clones were sequenced from two animals us-
ing overlapping primers. The RCM-CCR5 sequence are avail-
able from EMBL/GenBank/DDBJ under accession numbers
AF084002–AF084004 and AF094752–AF094753.
Results
Coreceptor Usage of SIVrcmGab1. SIVsm, SIVagm, and
SIVcpz are R5-tropic, divergent SIVs found in East, West,
and Central Africa (25–27, 30, 31). Because all naturally
occurring SIVs described thus far are R5-tropic, the core-
ceptor use of the new virus, SIVrcmGab1, was first tested
on GHOST cells expressing CD4 plus CCR5 or CXCR4
derived from humans and macaques. Unexpectedly, no en-
try was detected (data not shown). Known HIV-1 and SIV
strains were included to demonstrate the appropriate core-
ceptor function of each cell-type. To further examine
SIVrcm coreceptors, human chemokine receptors CCR1,
CCR2b, CCR3, CCR4, CCR5, CCR8, CXCR4,
STRL33 (Bonzo), and GPR15 (BOB) were tested in the
GHOST cell assay (Fig. 1). Among the SIV and HIV
strains tested, only SIVrcm entered CCR2b-expressing
cells (Fig. 1). This entry was blocked by anti-CD4 antibody
Leu-3a (data not shown), indicating CD4 dependency.
SIVmac, SIVagm, HIV-1JR-FL, and HIV-1ADA, primate
lentiviruses of known coreceptor useage, were included to
demonstrate appropriate activity of the cell lines (Fig. 1).
SIVrcm also used STRL33 (Bonzo), but with z10-fold2060 R2b-tropic SIV Infection in CCR5-deleted Mangabeys
less efficiency. However, low STRL33 expression could
not be excluded as the cause of inefficient STRL33 use,
because specific antibodies for testing STRL33 cell sur-
face expression are unavailable. The remaining chemokine
receptors, including GPR-15 (BOB), were not used by
SIVrcm.
Sequence Analysis of RCM-CCR5. To understand why
SIVrcm was uniquely R2b-tropic, but not R5-tropic,
among widely divergent HIVs and SIVs, full-length RCM-
CCR5 was amplified from the DNA of SIV-infected
RCM-009 and completely sequenced as previously de-
scribed (25). The RCM-009 CCR5 sequence was aligned
and compared with the SM consensus amino acid sequence
(31), which had been derived from four SMs naturally in-
fected with R5-tropic SIVsm in West Africa (31, 38). The
RCM sequence differed from SIVsm-infected SM CCR5
genes at only three amino acid positions, I42V, L146V and
P179S. However, a homozygous 24-bp deletion in the
CCR5 was identified from the SIV infected RCM-009
(Fig. 2). The deletion encompassed 8 amino acids in frame
in the fourth putative transmembrane region, upstream
from the D32 deletion found in the second extracellular
loop of human CCR5 (32). To test for spurious PCR dele-
tion artifacts, five additional CCR5 clones from RCM-009
were sequenced and had the identical deletion (data not
shown). Moreover, a limiting dilution of the original ge-
nomic DNA of RCM-009 showed that all 20 end point
PCR products gave the identical deletion by direct se-
quencing analysis, ruling out PCR artifacts (data not
shown). Identical results were also obtained using a total of
three pairs of PCR primers flanking the deletion region.
The identical homozygous deletion was also identified
from 10 additional RCMs (some are shown in Fig. 2) using
the above technique. Since limiting dilution allowed 20
separate amplifications of single molecules, artifacts be-
tween DNA products were avoided.
This deletion was not present in the CCR5 consensus
sequence obtained from four SMs (Fig. 2) naturally in-
fected in West Africa with four distinct R5 tropic viruses,
SIVsmSL92a, -c, -d, and -e (38). These results show that
two closely related but geographically isolated mangabey
sub-species were naturally infected with R5- or R2b-
tropic SIVs that correlated with homozygous full-length or
deleted CCR5 genes, respectively. The finding of an R2b-
tropic SIVrcm in a natural host having a homozygous
CCR5 defect suggested that SIV R2b tropism and defec-
tive CCR5 genes may be a related phenomenon.
Comparison of the Allelic Frequency of D24 CCR5 among
Geographically Isolated RCMs and SMs. To analyze the al-
lelic frequency of D24 deletions, genomic DNA was ex-
tracted from 14 additional RCMs from widely separate lo-
cations in Gabon and an American zoo colony. DNA was
analyzed from a total of six zoo-housed RCMs in America,
from eight household pets in Gabon, and from one fecal
sample collected fresh from a wild, free-living mangabey,
RCM-F3. PBMCs from the zoo mangabeys in the USA
and all household pets, except for RCM-009, were nega-
tive for SIVrcm antibodies by Western blot or culture and
PCR as previously described (9). RCM-CCR5 deletions
were detected using primers that specifically amplified a
213-bp fragment spanning the D24 region (Fig. 2). Four
zoo RCMs were homozygous D24 and two were het-
erozygous (Fig. 2). Fig. 2 shows the sequence of the D24
and wild-type DNA fragments from the zoo heterozygote,
RCM-1208, and two homozygotes from the zoo, RCM-
997 and -1049. Of the remaining seven household pets in
Gabon, five were homozygous for D24 CCR5 and two
were heterozygotes. RCM-009, the infected mangabey,
was homozygous for the CCR5 deletion (Fig. 2). No
RCMs on either continent were homozygous wild-type
for CCR5. Fecal DNA from RCM-F3, a wild, free-living
RCM, was also homozygous D24 CCR5 (data not shown).
Figure 1. Entry of primate lentiviruses
into GHOST cells expressing nine chemo-
kine receptors. HIV-1 pseudotyped viruses
contained R5-tropic envelopes from HIV-1
JR-FL and HIV-1 ADA or amphotropic
murine leukemia virus (AMuLV) envelope.
Infectious SIV strains were SIVmac1a11,
SIVagmTYO, and SIVrcmGab1. Negative
control cells were parental GHOST cells.2061 Chen et al.
To calculate an allelic frequency for D24, pedigree charts
from zoo animals were examined to determine if in-breed-
ing had occurred. Six zoo animals were unrelated. A sev-
enth was a full sibling and was therefore excluded from the
analysis. The pedigree charts also showed that the Ameri-
can and African groups could not be related, because of age
and birthplace. The household pet RCMs were also unre-
lated because they were wild-caught by their owners at dif-
ferent locations and kept alone with no known contact
with each other. The allelic frequency for D24 CCR5 for
the 15 RCMs on two continents was 86.6% (Table 1). In
marked contrast, none of 34 African pet or wild SMs were
homozygous for the D24, but 3 were found to be het-
erozygous, giving an allelic frequency of 4.1%, .20-fold
lower than RCMs (P , 0.001). All African SMs were also
unrelated because they were young, wild-caught house-
hold pets from different parts of two West African coun-
tries, Liberia and Sierra Leone. Fig. 2 shows the D24 dele-
tion found in an SIVsm-infected captive, SM-941, at the
Tulane Regional Primate Research Center. The data showed
a correlation between high wild-type and deleted CCR5
allelic frequencies with R5- and R2b-tropic viral infection.
CCR5 Genotyping of Primate Species. Taking the impor-
tance of the D32 defect to HIV transmission and AIDS
progression in humans into consideration, we screened a
Caucasian cohort for the D24 CCR5 genotype using the
CCR5-specific PCR method that was specific for the dele-
tion as described in Materials and Methods and shown in
Fig. 2. In a total of 409 individuals tested, 9 were homozy-
gous for D32, 41 were heterozygous for D32, and the re-
maining 306 were wild-type CCR5. The allelic frequency
was 7.3% (Table 1). All of the human samples were nega-
tive for the 189-bp fragment that is diagnostic for this dele-
tion (Table 1). Therefore, the D24 genotype identified in
RCMs must be rare or absent in Caucasian populations.
However, other human populations must be tested. In ad-
dition, we screened nine CPZs, 34 SMs, 7 lunulatus man-
gabeys, and 35 rhesus monkeys. Besides the three D24 het-
erozygous SMs described above, the other non-human
primates tested had neither D24 nor D32 CCR5 genotypes.
However, larger numbers of each simian species must be
tested.
Functional Analysis of RCM-CCR5. To test function of
RCM-CCR5 genes, signal transduction was tested by a
Ca21 influx assay as previously described (37). Methods
used for stable transfection of 293 cells with D24 or full
Figure 2. Alignment of CCR5 DNA fragments encompassing the D24
region of RCMs and other primates. CCR5 fragments were derived by
PCR of DNA from RCM-009, an SIVrcm-infected household pet in
Gabon, and American zoo animals 997, 1049, and 1208. SM-D24-CCR5
(SM-941) was from an SM housed at the Tulane Regional Primate Re-
search Center. RCM-CCR5 sequences were compared with consensus
human, CPZ, rhesus monkey, and SM (25, 31). The GGGTGGTG re-
combination sequences are in bold. Amino acid comparisons are shown in
single capital letters; gray box shows amino acids in the 24-bp deletion.
Table 1. Distribution of D32 and D24 CCR5 Genes in Humans and Non-human Primates
Primates Wild-type D24/D24 D24/wt‡ D32/D32 D32/wt
Total D32 bp or D24 bp
(allelic frequency)
Red-capped Mangabey
(Cercocebus torquatus torquatus) 0 11 4 0 0 15 (86.6%)
Sooty Mangabey
(Cercocebus torquatus atys) 31 0 3 0 0 34 (4.1%)
Caucasian Cohort 356 0 0 9 41 406 (7.3%)
(0–13.7%)*
White-crowned Mangabey
(Cercocebus torquatus lunulatus)7 0 0 0 0 7
Chimpanzee
(Pan troglodytes)9 0 0 0 0 9
Rhesus Monkey
(Macaca mulatta)3 5 0 0 0 0 3 5
*The range reported for different geographical human groups (40).
‡wt, wild-type.2062 R2b-tropic SIV Infection in CCR5-deleted Mangabeys
length RCM-CCR5 were reported (25). Quantitative
CCR5 gene expression was determined by measuring in-
tracellular levels of mRNA transcripts by reverse transcrip-
tion PCR assay (Fig. 3, A and B). Full length and deleted
transcripts were expressed at similar levels. MIP-1b was
used to induce signal transduction, because it is specific for
CCR5. MIP-1b induced Ca21 influx in 293T cells trans-
fected with RCM-wt-CCR5 (Fig. 3 C, right) but not in
RCM-D24-CCR5 transfected cells (Fig. 3 C, left). Assays
using RANTES gave similar results (data not shown).
Therefore, RCM-D24-CCR5 has lost physiologic function
for signaling, like the D32 CCR5 human allele (32).
The coreceptor function of RCM D24 and wild-type
CCR5 genes, obtained from the zoo heterozygote, were
further tested in transfected HOS.CD4 cells. The RCM-
CCR5–transfected HOS.CD4 cells were inoculated with
single-cycle HIV-1– or SIVmac-based luciferase reporter
viruses pseudotyped by various envelopes as previously re-
ported (25). When equal amounts of viruses were added,
no viral entry by any of eight R5-tropic viral envelopes
was detected in D24-RCM-CCR5 cells (Fig. 4 A). How-
ever coreceptor function of RCM-wt-CCR5 was intact
for each R5-tropic viral envelope (Fig. 4 A).
To determine if SIVrcm could replicate in cells express-
ing the homologous full-length CCR5 derived from its
own host species, SIVrcm was inoculated on HOS.CD4
cells expressing RCM-wt-CCR5 (Fig. 4). Replication as-
says were used because SIVrcm env clones are not yet avail-
able for the reporter assay. All six R5-tropic viruses, in-
cluding HIV-1, HIV-2, and highly divergent strains of SIV,
replicated in cells expressing RCM-wt-CCR5 (Fig. 4 B).
However, SIVrcm did not replicate in RCM-wt-CCR5
cells (Fig. 4 B). In contrast, SIVrcm was the only lentivirus
out of seven tested that replicated in cells transfected with
CCR2b (Fig. 4 C). Similar results were obtained using
U87.CD4.Hu-CCR2b. Therefore, SIVrcm could not use
its own full-length, functional CCR5.
Discussion
In this study we describe a natural SIV infection of an
RCM that was homozygous for a deletion in the CCR5
gene. The naturally occurring SIVrcm was found to be
R2b-tropic and not capable of using full-length human or
RCM-CCR5. Sequencing of the RCM-CCR5 revealed a
unique 24-bp deletion in the fourth transmembrane region.
Characterization of the D24 CCR5 allele showed that it
was common in both wild-caught RCMs in Gabon and in
unrelated captives in an American zoo. The overall D24 al-
lelic frequency was 86.6%, significantly higher than the
Figure 3. Calcium influx in 293 cells transfected with RCM-wt-
CCR5 and RCM-D24-CCR5. A shows 213-bp DNA fragments derived
from cells transfected with the wild-type CCR5 allele of RCM 1208
(lanes 1 and 2) and 189-bp fragments from the deleted allele of RCM-
1208 (lane 3) and -009 (lane 4). Lanes 5–8 show the same PCR reactions
without the reverse transcription step. Lanes 9 and M are buffer alone and
molecular weight markers, respectively. B shows quantitative PCR of the
213-bp fragment by end-point dilution as standards for comparing quanti-
ties of transcripts in cells in A. (C) Treatment with 200 nM MIP-1b re-
sulted in a peak of Ca21 influx in cells with RCM-wt-CCR5 (right) but
not in cells containing RCM-D24-CCR5 mRNA (left).
Figure 4. (A) Entry of luciferase reporter viruses into cells expressing
RCM-wt-CCR5 or RCM-D24-CCR5. Hos.CD4 cells were perma-
nently transfected with the pBabe vector alone, wt CCR5, or D24
CCR5. Two separate cell lines are shown for RCM-1208. Envelopes in
brackets are from a panel of R5-tropic lentiviruses. HIV-(A-MuLV) con-
tains an amphotropic murine leukemia virus envelope and was used as a
positive control for viral entry and synthesis. (B) Growth of SIV and HIV
in Hos.CD4 cells transfected with RCM-wt-CCR5 or CCR2b derived
from humans. R5 tropic viruses were as follows: j, HIV-1 (JR-FL);
d, HIV-1Z00979; m, HIV-2 A198411; r, HIV-2 A227011; s,
SIVmac239; and D, SIVcpzGab1. SIVrcmGab1 (h) did not infect cells
expressing wild-type CCR5 from its own host species (B). (C)
SIVrcmGab1 was the only lentivirus that replicated in CCR2b-expressing
cells.2063 Chen et al.
4.1% frequency found in SMs, a closely related species
from West Africa that was naturally infected with R5-
tropic SIVs (31). The wild-type and deleted CCR5 alleles
were cloned from a heterozygous RCM, because no ho-
mozygotes for wild-type CCR5 were found. Expression in
human cell lines showed that only the full-length wild-type
RCM-CCR5 was functional as a coreceptor for R5-tropic
HIV-1, HIV-2, SIVsm, and SIVmac strains. The full length
wild-type RCM-CCR5 allele was also capable of signaling
when tested for MIP-1b–induced calcium influx. Al-
though  D24 CCR5 mRNA was expressed in transfected
cells, the cells were inactive in signal transduction.
Since the 24-bp deletion encompasses eight amino acids
in frame, the deleted gene may be synthesized as a trun-
cated protein inside the cell. Stable cell surface expression
of the truncated protein is possible, but appears unlikely
because signal transduction was not detected (Fig. 3). The
deletion may adversely affect expression because it shortens
the membrane-spanning domain (Fig. 2) from 26 amino
acids to z19 amino acids. However, expression of D24
CCR5 with limited function is possible because the hydro-
phylic amino acids (R140 and R168) that determine fourth
transmembrane region properties were preserved. Ben-
kirane et al. (39) reported that the 32-bp deletion in the re-
gion of the second extracellular loop of the human CCR5
gene resulted in the loss of phosphorylation of the CCR5
gene product. The truncated CCR5 protein remained in
the endoplasmic reticulum and was not transported. Be-
cause the 24-bp deletion reported here is in-frame, and in
the fourth transmembrane domain, it is not possible to pre-
dict whether or not the mutation’s effect will be similar to
that observed by Benkirane et al. for the D32 deletion. Ad-
ditional studies are needed to characterize the 24-bp defect
and its effect on function, expression, and transport.
Although only 15 RCMs were tested, the data support a
naturally high frequency for the deleted allele. The high
frequency was found in two groups of RCMs on different
continents, a finding that could not be explained by in-
breeding. Furthermore, a high frequency of deleted genes
was also present in Gabonese household pets and in one
wild RCM. All Gabonese mangabey alleles were derived
from wild, free-living populations from different areas of
the country. In marked contrast, 34 household pet and
wild SMs from Sierra Leone and Liberia showed a signifi-
cantly lower frequency (4.1%) similar to the prevalence of
the D32 CCR5 found in certain human populations (40).
This cause for the high frequency in RCMs is unknown,
but may have been caused by the spread of a small founder
population of RCMs. Comparative genetic studies be-
tween SMs and RCMs could be used to determine if there
was a bottle neck effect on the RCM sub-species that pro-
duced the high frequency of deleted CCR5 genes and a
unique SIV–host relationship.
Hypotheses have been proposed that the appearance of
the human CCR5 deletion was in response to a past epi-
demic in which the loss of the CCR5 gene conferred resis-
tance against an epidemic agent (40). Similar forces may
have been involved in the selection of the mangabey
defect. The deletions in mangabeys and humans may repre-
sent convergent evolution, due to similar ecological pres-
sures. However, their temporal occurrence and geographi-
cal distributions appear to be highly discordant, based on
results thus far. The historic ranges and dispersals of SMs
and RCMs containing the D24 CCR5 deletion indicate
that this genetic defect arose some time before mangabey
subspeciation. Subspeciation of these coastal mangabeys de-
veloped more than 10,000 yr ago due to natural barriers
that formed in their range. The Dahomey gap, which is a
900-km Savannah break in upper and lower guinea forest,
is one such barrier. Rivers in the Dahomey gap may also
have been barriers that contributed to development of the
subspecies (41). This date is significantly older than the 700
yr estimate for the age of the 32-bp CCR5 deletion in hu-
mans (40). Why the mangabey CCR5 deletion would be
much older than the human deletion remains to be deter-
mined. The difference in ages of the two defects suggest
that the selective pressures for the deletions were different
or were caused by similar events widely separated in time.
The mangabey and human CCR5 deletions are also dis-
cordant in geographical distribution. The human D32 is
most common in Northern Europeans and is absent among
populations native to Africa (40). In marked contrast, the
mangabey CCR5 deletion was found in equatorial African
mangabeys. The discordance in D24 CCR5 distributions
further indicates that the selective pressures for the emer-
gence of the mutations occurred under quite different cir-
cumstances.
Other primate species, including macaques, CPZs, and
humans, have the same possible recombination site, GGG-
TGGTG (Fig. 2), but the deletion was not found in .400
individuals tested from these three species (Table 1). More
monkeys, as well as more humans, must be tested to extend
these results. The finding of a deleted CCR5 allele in a
more readily available research monkey species such as the
macaque would be useful for pathogenic studies.
This study also raises questions about the origin of R2b
tropism in SIV. This tropism is unknown among highly di-
vergent SIVsm, SIVmac, SIVagm, and SIVcpz, all of which
are R5-tropic (25–28, 30, 31). R5-tropic SIV strains origi-
nated from different parts of Africa, showing their wide-
spread distribution among naturally infected simian species.
Therefore, it is possible that SIVrcm was derived from the
more common R5-tropic SIV and switched its tropism to
CCR2-based coreceptors in response to the appearance of
deleted CCR5 genes at high frequencies in its host.
SIVrcm R2b-tropism may have arisen when RCMs be-
came a separate, isolated subspecies in relatively ancient
times.
Adaptation of SIV from CCR5 to CCR2b would re-
quire an intermediate coreceptor. Such a coreceptor is
available for SIVrcm, based on in vitro studies that showed
that the virus used STRL-33 (Fig. 1). Because SIVrcm and
all other SIVs are dual tropic (Fig. 1 and references 25, 28,
30, 31), R5-tropic ancestors of SIVrcm may have repli-
cated in mangabey hosts using a minor coreceptor and then
adapted to CCR2-based coreceptors, the closest chemo-2064 R2b-tropic SIV Infection in CCR5-deleted Mangabeys
kine coreceptor to CCR5 (42, 43). This hypothesis can be
tested by infecting homozygous deleted mangabeys with
R5-tropic SIV. If selective pressure can induce coreceptor
switches, then the selection pressure from CCR5-directed
drug therapy may cause viral adaptation to other corecep-
tors resulting in drug resistance. This concern is raised be-
cause it has been shown that certain HIV-1 strains used
CCR2b as a coreceptor, and changes in coreceptor tropism
are known to occur in HIV-1–infected people (42–44).
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